BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 9925834)

  • 1. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants.
    Baker JW; Mellon M; Wald J; Welch M; Cruz-Rivera M; Walton-Bowen K
    Pediatrics; 1999 Feb; 103(2):414-21. PubMed ID: 9925834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of budesonide inhalation suspension: a nebulizable corticosteroid for persistent asthma in infants and young children.
    White MV; Cruz-Rivera M; Walton-Bowen K
    Fam Med; 1999 May; 31(5):337-45. PubMed ID: 10407712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of budesonide inhalation suspension in infants and young children with persistent asthma. Budesonide Inhalation Suspension Study Group.
    Mellon M
    J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):191-9. PubMed ID: 10518846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma.
    Shapiro G; Mendelson L; Kraemer MJ; Cruz-Rivera M; Walton-Bowen K; Smith JA
    J Allergy Clin Immunol; 1998 Nov; 102(5):789-96. PubMed ID: 9819296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
    Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
    Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children.
    Kemp JP; Skoner DP; Szefler SJ; Walton-Bowen K; Cruz-Rivera M; Smith JA
    Ann Allergy Asthma Immunol; 1999 Sep; 83(3):231-9. PubMed ID: 10507269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma.
    Scott MB; Skoner DP
    J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):200-9. PubMed ID: 10518847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids.
    Shapiro GG; Mendelson LM; Pearlman DS
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):633-40. PubMed ID: 11428735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma.
    Skoner DP; Szefler SJ; Welch M; Walton-Bowen K; Cruz-Rivera M; Smith JA
    J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):259-68. PubMed ID: 10669845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily budesonide inhalation suspension in infants and children < 4 and > or = 4 years of age with persistent asthma.
    Scott MB; Ellis MH; Cruz-Rivera M; Fitzpatrick S; Smith JA
    Ann Allergy Asthma Immunol; 2001 Dec; 87(6):488-95. PubMed ID: 11770696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma.
    Mellon M; Leflein J; Walton-Bowen K; Cruz-Rivera M; Fitzpatrick S; Smith JA
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):593-8. PubMed ID: 10934092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.
    Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B
    Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
    ZuWallack R; Adelglass J; Clifford DP; Duke SP; Wire PD; Faris M; Harding SM
    Chest; 2000 Aug; 118(2):303-12. PubMed ID: 10936117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of efficacy and safety of budesonide delivered via two dry powder inhalers.
    Kerwin EM; Pearlman DS; de Guia T; Carlsson LG; Gillen M; Uryniak T; Simonson SG
    Curr Med Res Opin; 2008 May; 24(5):1497-510. PubMed ID: 18419878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
    Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
    Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids.
    D'Urzo A; Karpel JP; Busse WW; Boulet LP; Monahan ME; Lutsky B; Staudinger H
    Curr Med Res Opin; 2005 Aug; 21(8):1281-9. PubMed ID: 16083538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma.
    Banov CH; Howland WC; Lumry WR
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):627-32. PubMed ID: 11428734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders.
    Hvizdos KM; Jarvis B
    Drugs; 2000 Nov; 60(5):1141-78. PubMed ID: 11129126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma.
    Berger WE; Bleecker ER; O'Dowd L; Miller CJ; Mezzanotte W
    Allergy Asthma Proc; 2010; 31(1):49-59. PubMed ID: 20167145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.